Literature DB >> 10810207

Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant?

J Li1, H Sasaki, Y L Sheng, D Schneiderman, C W Xiao, F Kotsuji, B K Tsang.   

Abstract

Cisplatin-induced apoptosis in epithelial ovarian cancer cells is in part a consequence of suppressed Xiap expression and upregulation of the Fas/FasL system. Changes in the expression of these 'cell death' and 'cell survival' genes lead to activation of caspase-3, and cleavage of MDM2 and FAK. Failure of cancer cells to maintain a balance in the expression of these genes in favor of apoptotic cell death may be an important factor of chemoresistance. Xiap may be a novel target for gene therapy of human ovarian epithelial cancer and, dependent on P53 status, expression of Xiap antisense alone or in combination with wild-type P53 sense may offer a new approach for the treatment of the chemoresistant cancer. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810207     DOI: 10.1159/000014631

Source DB:  PubMed          Journal:  Biol Signals Recept        ISSN: 1422-4933


  11 in total

Review 1.  Ovarian cancer stem cells and inflammation.

Authors:  Gil Mor; Gang Yin; Ilana Chefetz; Yang Yang; Ayesha Alvero
Journal:  Cancer Biol Ther       Date:  2011-04-15       Impact factor: 4.742

Review 2.  Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwendlyn Kollmorgen; Rüdiger Rueger
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

3.  Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.

Authors:  Arnon P Kater; Frank Dicker; Massimo Mangiola; Kate Welsh; Richard Houghten; John Ostresh; Adel Nefzi; John C Reed; Clemencia Pinilla; Thomas J Kipps
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

4.  Decreased placental X-linked inhibitor of apoptosis protein in an ovine model of intrauterine growth restriction.

Authors:  Juan A Arroyo; Russell V Anthony; Henry L Galan
Journal:  Am J Obstet Gynecol       Date:  2008-03-04       Impact factor: 8.661

5.  MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.

Authors:  Wei Chen; Liuxuan Huang; Chenjun Hao; Wenshu Zeng; Xu Luo; Xiaodi Li; Longshu Zhou; Songshan Jiang; Zheng Chen; Yuanli He
Journal:  Tumour Biol       Date:  2016-01-15

6.  microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.

Authors:  Xiaodi Li; Wei Chen; Wenshu Zeng; Chunling Wan; Shiwei Duan; Songshan Jiang
Journal:  Br J Cancer       Date:  2016-11-22       Impact factor: 7.640

Review 7.  Chemoresistance and targeted therapies in ovarian and endometrial cancers.

Authors:  Kevin Brasseur; Nicolas Gévry; Eric Asselin
Journal:  Oncotarget       Date:  2017-01-17

8.  New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action.

Authors:  Kateryna Ohui; Eleonora Afanasenko; Felix Bacher; Rachel Lim Xue Ting; Ayesha Zafar; Núria Blanco-Cabra; Eduard Torrents; Orsolya Dömötör; Nóra V May; Denisa Darvasiova; Éva A Enyedy; Ana Popović-Bijelić; Jóhannes Reynisson; Peter Rapta; Maria V Babak; Giorgia Pastorin; Vladimir B Arion
Journal:  J Med Chem       Date:  2018-12-18       Impact factor: 7.446

9.  Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas.

Authors:  Y Yan; C Mahotka; S Heikaus; T Shibata; N Wethkamp; J Liebmann; C V Suschek; Y Guo; H E Gabbert; C D Gerharz; U Ramp
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

10.  Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells.

Authors:  Zhang-Feng Zhong; Wen Tan; Sheng-Peng Wang; Wen-An Qiang; Yi-Tao Wang
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.